The Bridge

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

An Idea Sparked in San Marcos This ain't your typical cocktail party chat. We're diving into a story born from necessity—where someone's trying to shave seconds off a life-or-death situation. From the busy streets of San Marcos, California, an inventor has brought a practical gem to the table: the LIFE STROBE. This gizmo is not just a bulb with a new flash pattern. It's...

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Cresilon Partners with McCarthy Vet to Distribute VETIGEL Cresilon Inc., an innovative biotechnology firm known for its advanced hemostatic products, has announced a transformative agreement with McCarthy Vet. This collaboration marks a significant step forward as it allows for the distribution of VETIGEL, a groundbreaking hemostatic gel, directly to veterinary surgeons....

Absci Corporation's Upcoming Financial Reports Absci Corporation (Nasdaq: ABSI), recognized as a pioneer in data-driven generative AI for drug discovery, is gearing up to release important business updates along with financial results for the first quarter of 2025. This report is scheduled to be unveiled subsequent to market close. Key Highlights of the Upcoming Report...

Borregaard ASA's Second Quarter Results Announcement Borregaard ASA, a renowned name in biochemistry, is set to present its Q2 2025 results. This event will take place on Wednesday, coinciding with July 16, 2025, at 07:00 CEST. As anticipated, a comprehensive stock exchange announcement will follow shortly thereafter. What to Expect from the Presentation The presentation...

JP Conte's Bet on Brazilian Waste-to-Energy Giant Here's the scoop, folks. Lupine Crest Capital, helmed by none other than JP Conte, just doubled down on their investment in Brazil. This isn't some negligible penny-ante increase, but a hefty infusion of R$70 million—think roughly $14 million in USD—into Orizon Valorização de Resíduos S.A., the notable...

Hedge funds adjusted their playbooks back then in 2023, net selling equities amid a flurry of options expiry and index rebalancing. The desks were abuzz as they noted slight selling pressure from these funds, yet after the dust settled on that chaotic week, buying picked up noticeably—especially Thursday when it seemed traders found some footing again. Macro Products...